| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | EP1192119B1 Process for the preparation of 3,3-dimethylbutanal |
| 03/22/2006 | EP1179008B1 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/22/2006 | EP0933379B1 Novel peptide derivatives having thiazolyl-alanine residue |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/21/2006 | US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine. |
| 03/21/2006 | US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2005111008A3 Compounds for enzyme inhibition |
| 03/16/2006 | US20060058570 Radioactive member and method of making |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058242 Dipeptide derivatives |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/15/2006 | EP1633774A1 Macrocyclic antagonists of the motilin receptor |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |
| 03/15/2006 | EP1633702A1 Protease inhibitors |
| 03/15/2006 | EP1633381A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 03/15/2006 | EP1633380A2 Antimicrobial and anticancer lipopeptides |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/14/2006 | US7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays |
| 03/14/2006 | US7012066 for coadministration with interferon and antiviral agent |
| 03/14/2006 | US7011860 Flavor precursor composition and method for releasing the flavor component |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/09/2006 | WO2006026352A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 03/09/2006 | WO2006024741A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | WO2005122379A9 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052311 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP) |
| 03/09/2006 | DE10040380B4 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| 03/09/2006 | CA2577812A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 03/09/2006 | CA2572442A1 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631674A2 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 03/08/2006 | CN1745175A Active immunization to generate antibodies to soluble A-beta |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008928 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/02/2006 | WO2006023396A2 Vla-4 antagonists |
| 03/02/2006 | WO2006021413A1 Alpha-keto carbonyl calpain inhibitors |
| 03/02/2006 | WO2006021409A1 Alpha-keto carbonyl calpain inhibitors |
| 03/02/2006 | WO2005070827A3 Fullerene based amino acids |
| 03/02/2006 | US20060046966 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/02/2006 | US20060046965 racemic mixtures, stereoisomers or optical isomers, useful as protease inhibitors; viricides |
| 03/02/2006 | US20060046963 Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use |
| 03/02/2006 | US20060046956 Acylsulfonamide compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | DE4228295B4 N-(N'-langkettiges Acyl-Beta-Alanyl)-Beta-Alanin oder dessen Salz und diese enthaltende Detergenszusammensetzungen N- (N'-long-chain acyl-beta-alanyl) -beta-alanine or a salt thereof and detergent compositions containing them |
| 03/02/2006 | CA2578006A1 Alpha-keto carbonyl calpain inhibitors |
| 03/02/2006 | CA2577987A1 Alpha-keto carbonyl calpain inhibitors |
| 03/02/2006 | CA2574280A1 Alanine 2, 3 aminomutases |
| 03/01/2006 | EP1630171A1 Streptavidin binding peptides |
| 03/01/2006 | EP1630169A2 Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production |
| 03/01/2006 | EP1630168A2 Molecular mimetics of meningococcal B peptides |
| 03/01/2006 | EP1629000A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/01/2006 | EP1628999A2 Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth |
| 03/01/2006 | EP1628995A1 A process for the preparation of perindopril using tetramethyluronium salts as coupling reagents |
| 03/01/2006 | EP1628965A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 03/01/2006 | EP1628956A1 A process for the preparation of compounds having an ace inhibitory action |
| 03/01/2006 | EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP1328657B1 Process for detecting serine/threonine kinase activity |
| 03/01/2006 | EP1256590B1 Method for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | EP0979241B1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 03/01/2006 | EP0750507B2 Proteasome regulation of nf-kappa-b activity |
| 03/01/2006 | CN1742089A Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 03/01/2006 | CN1740188A Prepn process of glycylglutamine |
| 03/01/2006 | CN1740173A Inhibitors of interleukin-1beta converting enzyme |
| 03/01/2006 | CN1740143A Prepn process of metal-amino acid chelate |
| 03/01/2006 | CN1243567C Growth hormone secretagogues |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/23/2006 | WO2006019632A2 Cell adhesion inhibitors |
| 02/23/2006 | WO2005105843A3 Hiv protease inhibitors |
| 02/23/2006 | US20060041946 Nuclear transfer nuclei from histone hypomethylated donor cells |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040253 Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/22/2006 | EP1627884A1 Process for producing dipeptides |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1626732A2 Means for preventing and treating cellular death and their biological applications |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | CN1739029A Prion protein ligands and methods of use |
| 02/22/2006 | CN1738896A Composition and method for treating lupus nephritis |
| 02/22/2006 | CN1738830A 培哚普利 Perindopril |
| 02/22/2006 | CN1737009A Polypeptide compound and its medicinal uses |
| 02/21/2006 | US7001984 Oligopeptides which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using compounds for |
| 02/21/2006 | US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |